Practice the beginning of the jade, and never stop to go far. From March 21 to 24, 2024, the 36th Zhejiang International Scientific Research, Medical Equipment Technology Exchange Exhibition was successfully held in Hangzhou International Expo Center.
The theme of this exhibition is “New scenarios, new technologies, new trends”, during which various activities not only show new technologies and new achievements in the field of medical and health, but also build a platform for technical exchange and achievement transformation for academic institutions and innovative enterprises.
At the exhibition site, Big Vision carried automatic artificial intelligence OCT, vision screening instrument, bright lemon eye health intelligent management cloud platform (eye optic management system, children and adolescents myopia prevention and control and early warning system) and other intelligent ophthalmology hardware and software equipment, attracting many visitors and experts to stop and experience.
Chronic diseases such as diabetes are a serious threat to the health of Chinese residents. In the screening and prevention of chronic eye complications, the dual-mode AI algorithm combined with fundus color imaging and optical coherence tomography (OCT) has higher sensitivity and specificity than the single fundus color imaging AI. By combining the images of OCT and fundus cameras, doctors can more accurately assess the development of the disease, develop personalized treatment plans, and carry out regular monitoring to help patients intervene and manage chronic diseases in a timely manner, improve the treatment effect, and help chronic disease prevention and management level rise.
During the exhibition, Big Vision Medical’s intelligent ophthalmic equipment attracted the attention and interviews of authoritative media such as China news and Zhejiang Daily.
Zhejiang Daily, China News Network and other media have carried out in-depth reports on Bigway Medical’s ophthalmic AI innovation achievements, deeply feeling that the application of AI technology is of great significance in the field of grassroots chronic disease management, which can provide remote areas and grassroots health institutions with a system solution for screening subtle and early fundus lesions, and realize the universal treatment and management of chronic eye complications. At present, it has been applied in more than 400 medical institutions across the country, successfully serving more than 150,000 people, and escorting the eye health of the whole people.
Big Vision automated artificial intelligence OCT provides doctors with strong diagnosis and treatment support with the characteristics of convenient and efficient operation and AI precision diagnosis. In primary medical care, the application of this technology effectively improves the efficiency of ophthalmic diagnosis and treatment, and successfully alleviates the problems of fewer ophthalmologists and difficult examination of eye diseases. In the future, Bigwig hopes to benefit more patients through this innovative application.
No comments yet.